Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
L’INSEAD brandit l'innovation comme force au service du bien Lors de cet événement organisé par l’INSEAD, le plus grand au...
-
INSEAD Showcases Innovation as a Force for Good Largest INSEAD Middle East event advances the school’s vision and its biggest fundraising...
-
Washington, DC, March 05, 2019 (GLOBE NEWSWIRE) -- The District of Columbia Housing Finance Agency (DCHFA) has appointed Monte J. Stanford as the Chief Operating Officer (COO). As COO, Stanford will...
-
LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- The global autoimmune disease diagnostics market is forecasted to grow at a stable CAGR around 2.8% during the forecast period 2018 to 2026 and market...
-
Organization pledges additional $1 million to bring total funding to 20,000 credit-bearing exam feesModernStates.org gained 120,000 students in first 17 months, offering free college courses online...
-
Biogen to acquire Nightstar for US$ 25.50 per share in cashTransaction expected to be completed by mid-year 2019 WALTHAM, Mass. and LONDON, March 04, 2019 (GLOBE NEWSWIRE) -- Nightstar Therapeutics...
-
Chapel Hill, NC, March 01, 2019 (GLOBE NEWSWIRE) -- More than four million Americans over the age of 40 are visually impaired, and that population is estimated to nearly double by 2030. Every...
-
Chapel Hill, N.C. , Feb. 28, 2019 (GLOBE NEWSWIRE) -- More than four million Americans over the age of 40 are visually impaired, and that population is estimated to nearly double by 2030. Every...
-
Chapel Hill, N.C. , Feb. 27, 2019 (GLOBE NEWSWIRE) -- More than four million Americans over the age of 40 are visually impaired, and that population is estimated to nearly double by 2030. Every...
-
- CX-2009, a First-in-Class Probody Drug Conjugate Targeting CD166, Demonstrates Encouraging Anti-Cancer Activity in Multiple Tumor Types and Safety in Phase 1 Dose Escalation - - CX-072, A...